No Data
Unusual Options Activity: CVS, BSX and Others Attract Market Bets, CVS V/OI Ratio Reaches 405.0
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
Citigroup Adjusts Boston Scientific Price Target to $107 From $98, Maintains Buy Rating
Boston Scientific Is Maintained at Overweight by Wells Fargo
Express News | Boston Scientific Cmo Discuss Solutions for Health Inequality on Today's Marketplace
Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace